If you have questions about whether the medication is producing a meaningful effect, discuss these with your trial clinician rather than making any self-adjustment to the dose
A balanced microbiome, one with plenty of diverse, beneficial species, supports better GLP-1 signaling
Melatonin: a clinical perspective
Results: GLP-1RAs attenuate inflammation by suppressing NF-B and p38 MAPK pathways, reduce oxidative stress, enhance insulin sensitivity, and promote mitochondrial and endothelial stability
Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence